Cyberonics Inc (CYBX)

CYBX (NASDAQ:Health Services)
$52.18
pos +0.00
+0.00%
Today's Range: 51.02 - 55.08 | CYBX Avg Daily Volume: 358,900
Last Update: 11/21/14 - 3:59 PM EST
Volume: 0
YTD Performance: -20.24%
Open: $0.00
Previous Close: $55.01
52 Week Range: $48.19 - $73.52
Oustanding Shares: 26,624,906
Market Cap: 1,464,636,079
6-Month Chart
TheStreet Ratings Grade for CYBX
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 6 6 6 6
Moderate Buy 0 0 0 0
Hold 2 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.50 1.50 1.50 1.50
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 23.51
Price Earnings Comparisons:
CYBX Sector Avg. S&P 500
23.51 25.10 25.70
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-10.45% -22.68% 74.46%
GROWTH 12 Mo 3 Yr CAGR
Revenue 10.90 0.48 0.14
Net Income 18.40 0.17 0.05
EPS 20.70 0.21 0.06
Earnings for CYBX:
EBITDA 0.09B
Revenue 0.28B
Average Earnings Estimates
Qtr (01/15) Qtr (04/15) FY (04/15) FY (04/16)
Average Estimate $0.57 $0.66 $2.34 $2.74
Number of Analysts 5 5 6 5
High Estimate $0.60 $0.68 $2.36 $2.77
Low Estimate $0.54 $0.63 $2.33 $2.70
Prior Year $0.51 $0.55 $2.04 $2.34
Growth Rate (Year over Year) 12.16% 19.27% 14.62% 17.26%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Bearish
Nov 21, 2014 | 7:34 AM EST
CYBX was downgraded to Neutral, Sterne Agee said. Domestic sales have stalled and growth headwinds remain. 
Bearish
Aug 22, 2014 | 7:12 AM EDT
CYBX was downgraded from Buy to Hold, Canaccord Genuity said. $52 price target. New U.S. patient growth is slowing. 
Bullish
Jun 06, 2013 | 8:34 AM EDT
CYBX earnings estimates were increased on raised guidance as strength is seen across the U.S. and Europe, Lazard Capital. Price target ...
Bullish
Mar 04, 2013 | 7:22 AM EST
CYBX was upgraded to Buy, Lazard Capital Market said. A proprietary survey showed that sales reps were not using inappropriate sales ta...
Bullish
Nov 19, 2012 | 8:43 AM EST
Shares of CYBX now seen reaching $57, Canaccord said. Estimates also raised on a record quarter. Buy rating.
Bullish
Aug 29, 2012 | 6:35 AM EDT
CYBX was upgraded from Hold to Buy, Canaccord Genuity said. $56 price target. Company continues to execute well and depression treatmen...

Take Two, Leave Two Real Money Pro($)

I’m making trades in Movado and Sanderson Farms but passing on Cyberonics and PVH.

Still Some Earnings out There Real Money Pro($)

There are four reports coming up I find interesting.

Contributor Ken Shreve takes a look at upcoming economic data and some key earnings reports for the week of Aug. 27

These promising medical-device names aren’t on the S&P, but they deserve plenty of attention.

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.